Table 3. Comparison of the incidences of different outcomes in patients with and without IABP implantation.
ECMO (N = 227) | IABP plus ECMO (N = 302) | p | |
---|---|---|---|
ECMO duration, days | 4.0 (2.0–8.0) | 4.0 (2.0–8.0) | 0.964 |
IABP timing | |||
IABP initiation, hrs | N/A | 0.0 (0.0–0.0) | N/A |
IABP duration, days | N/A | 5.0 (3.0–8.0) | N/A |
Organ failure | |||
Brain | 39.6 | 44.4 | 0.287 |
Lung | 32.2 | 38.4 | 0.143 |
Heart | 57.7 | 60.3 | 0.592 |
Liver | 26.4 | 19.2 | 0.057 |
Kidney | 48.9 | 52.3 | 0.482 |
Gastro-intestine | 15.0 | 9.9 | 0.082 |
Vascular complications | |||
Need reperfusion | 47.1 | 49.3 | 0.660 |
Fasciotomy | 0.0 | 2.6 | 0.012 |
Digital gangrene | 9.7 | 7.6 | 0.433 |
Bridge to VAD or transplantation | |||
VAD | 0.9 | 0.0 | 0.184 |
Heart transplantation | 7.5 | 4.0 | 0.085 |
Two weeks mortality, % | 48.5 | 47.7 | 0.861 |
Mortality etiologies | 0.830 | ||
MOF | 92.2 | 94.2 | |
Brain death | 2.8 | 3.2 | |
Major bleeding | 1.4 | 1.1 | |
Others | 3.5 | 1.6 |
Abbreviations: ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter-pulsation; MOF, multi-organ failure (more than two organ dysfunction).